Actualizaciones regulatorias

The Pharmaceuticals and Medical Devices Agency (PMDA) has posted the schedule for the upcoming JP19‑I publication.

The Pharmaceuticals and Medical Devices Agency announces a symposium to mark the 10th anniversary of its Hokuriku Branch.

The Pharmaceuticals and Medical Devices Agency (PMDA) has posted the report from the PMDA-ATC 10th Anniversary Ceremony.

The Pharmaceuticals and Medical Devices Agency (PMDA) has posted an updated list of approved medical devices covering April 2004 to September 2025.

The Pharmaceuticals and Medical Devices Agency (PMDA) posted its PDG March 2026 news on June 12, 2026.

Japan’s Pharmaceuticals and Medical Devices Agency has released an updated list of drugs approved from April 2004 through February 2026. The list is available on the PMDA website.

Japan’s PMDA has approved the SHINSA companion diagnostic (CDx) to help identify patients eligible for specific therapies, updated June 16, 2026.

The Pharmaceuticals and Medical Devices Agency (PMDA) announced the conclusion of a Memorandum of Understanding with the Medical University of Vienna, as detailed in a June 30, 2026 news release.

The Pharmaceuticals and Medical Devices Agency (PMDA) has posted Safety Information No.429, providing recent safety updates for drugs and devices in Japan.

The Pharmaceuticals and Medical Devices Agency (PMDA) has posted its 2026 No.2 update, providing the latest regulatory information for stakeholders.

The Japan Pharmaceuticals and Medical Devices Agency announced a new press release covering its international pharmacopoeia initiatives.

Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has released an English translation of its review report for the pharmaceutical product RiHEART, available on its website.